Cargando…

Maternal Morbidity in Women with Placenta Previa Managed with Prediction of Morbidly Adherent Placenta by Ultrasonography

Objective. To determine maternal morbidity in women with placenta previa managed with prediction of morbidly adherent placenta (MAP) by ultrasonography. Methods. A retrospective cohort study was undertaken comprising forty-one women who had placenta previa with or without risk factors for MAP. Women...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujisaki, Midori, Furukawa, Seishi, Maki, Yohei, Oohashi, Masanao, Doi, Koutarou, Sameshima, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421082/
https://www.ncbi.nlm.nih.gov/pubmed/28523191
http://dx.doi.org/10.1155/2017/8318751
_version_ 1783234531787014144
author Fujisaki, Midori
Furukawa, Seishi
Maki, Yohei
Oohashi, Masanao
Doi, Koutarou
Sameshima, Hiroshi
author_facet Fujisaki, Midori
Furukawa, Seishi
Maki, Yohei
Oohashi, Masanao
Doi, Koutarou
Sameshima, Hiroshi
author_sort Fujisaki, Midori
collection PubMed
description Objective. To determine maternal morbidity in women with placenta previa managed with prediction of morbidly adherent placenta (MAP) by ultrasonography. Methods. A retrospective cohort study was undertaken comprising forty-one women who had placenta previa with or without risk factors for MAP. Women who had all three findings (bladder line interruption, placental lacunae, and absence of the retroplacental clear zone) were regarded as high suspicion for MAP and underwent cesarean section followed by hysterectomy. We attempted placental removal for women having two findings or less. Results. Among 28 women with risk, nine with high suspicion underwent hysterectomy and were diagnosed with MAP. Three of 19 women with two findings or less eventually underwent hysterectomy and were diagnosed with MAP. The sensitivity and positive predictive value for the detection of MAP were 64% and 100%. The pathological severity of MAP was significantly correlated with the cumulative number of findings. There were no cases of MAP among 13 women without risk. There was no difference of blood loss between women with high suspicion and those without risk (2186 ± 1438 ml versus 1656 ± 848 ml, resp.; p = 0.34). Conclusion. Management with prediction of MAP by ultrasonography is useful for obtaining permissible morbidity.
format Online
Article
Text
id pubmed-5421082
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-54210822017-05-18 Maternal Morbidity in Women with Placenta Previa Managed with Prediction of Morbidly Adherent Placenta by Ultrasonography Fujisaki, Midori Furukawa, Seishi Maki, Yohei Oohashi, Masanao Doi, Koutarou Sameshima, Hiroshi J Pregnancy Research Article Objective. To determine maternal morbidity in women with placenta previa managed with prediction of morbidly adherent placenta (MAP) by ultrasonography. Methods. A retrospective cohort study was undertaken comprising forty-one women who had placenta previa with or without risk factors for MAP. Women who had all three findings (bladder line interruption, placental lacunae, and absence of the retroplacental clear zone) were regarded as high suspicion for MAP and underwent cesarean section followed by hysterectomy. We attempted placental removal for women having two findings or less. Results. Among 28 women with risk, nine with high suspicion underwent hysterectomy and were diagnosed with MAP. Three of 19 women with two findings or less eventually underwent hysterectomy and were diagnosed with MAP. The sensitivity and positive predictive value for the detection of MAP were 64% and 100%. The pathological severity of MAP was significantly correlated with the cumulative number of findings. There were no cases of MAP among 13 women without risk. There was no difference of blood loss between women with high suspicion and those without risk (2186 ± 1438 ml versus 1656 ± 848 ml, resp.; p = 0.34). Conclusion. Management with prediction of MAP by ultrasonography is useful for obtaining permissible morbidity. Hindawi 2017 2017-04-24 /pmc/articles/PMC5421082/ /pubmed/28523191 http://dx.doi.org/10.1155/2017/8318751 Text en Copyright © 2017 Midori Fujisaki et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Fujisaki, Midori
Furukawa, Seishi
Maki, Yohei
Oohashi, Masanao
Doi, Koutarou
Sameshima, Hiroshi
Maternal Morbidity in Women with Placenta Previa Managed with Prediction of Morbidly Adherent Placenta by Ultrasonography
title Maternal Morbidity in Women with Placenta Previa Managed with Prediction of Morbidly Adherent Placenta by Ultrasonography
title_full Maternal Morbidity in Women with Placenta Previa Managed with Prediction of Morbidly Adherent Placenta by Ultrasonography
title_fullStr Maternal Morbidity in Women with Placenta Previa Managed with Prediction of Morbidly Adherent Placenta by Ultrasonography
title_full_unstemmed Maternal Morbidity in Women with Placenta Previa Managed with Prediction of Morbidly Adherent Placenta by Ultrasonography
title_short Maternal Morbidity in Women with Placenta Previa Managed with Prediction of Morbidly Adherent Placenta by Ultrasonography
title_sort maternal morbidity in women with placenta previa managed with prediction of morbidly adherent placenta by ultrasonography
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421082/
https://www.ncbi.nlm.nih.gov/pubmed/28523191
http://dx.doi.org/10.1155/2017/8318751
work_keys_str_mv AT fujisakimidori maternalmorbidityinwomenwithplacentapreviamanagedwithpredictionofmorbidlyadherentplacentabyultrasonography
AT furukawaseishi maternalmorbidityinwomenwithplacentapreviamanagedwithpredictionofmorbidlyadherentplacentabyultrasonography
AT makiyohei maternalmorbidityinwomenwithplacentapreviamanagedwithpredictionofmorbidlyadherentplacentabyultrasonography
AT oohashimasanao maternalmorbidityinwomenwithplacentapreviamanagedwithpredictionofmorbidlyadherentplacentabyultrasonography
AT doikoutarou maternalmorbidityinwomenwithplacentapreviamanagedwithpredictionofmorbidlyadherentplacentabyultrasonography
AT sameshimahiroshi maternalmorbidityinwomenwithplacentapreviamanagedwithpredictionofmorbidlyadherentplacentabyultrasonography